<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02856932</url>
  </required_header>
  <id_info>
    <org_study_id>CEBD-CU-2016-08-178</org_study_id>
    <nct_id>NCT02856932</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of Glass Ionomer With Glass Hybrid Technology Versus Conventional High Viscosity Glass Ionomer in Class I Cavities of High Caries Risk Patients</brief_title>
  <official_title>Clinical Evaluation of Glass Ionomer With Glass Hybrid Technology Versus Conventional High Viscosity Glass Ionomer in Class I Cavities of High Caries Risk Patients: Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <brief_summary>
    <textblock>
      PICOTS:

      P: High Caries Risk Patients with bilateral class I cavities. I: Glass Ionomer with Glass
      Hybrid Technology. C: Conventional High Viscosity Glass Ionomer. O: Clinical performance
      (Functional properties Biological properties) using (World Dental Federation) Fédération
      dentaire internationale (FDI) criteria for dental restorations.

      T: 1 year. S: Randomized controlled Trial (split mouth design). Research question:In high
      caries risk patients with class I cavities will glass ionomer with glass hybrid technology
      has similar clinical performance as conventional high viscosity glass ionomer
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical performance using FDI criteria for dental restorations (functional properties and biological properties)</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">31</enrollment>
  <condition>Class I Cavities in High Caries Risk</condition>
  <arm_group>
    <arm_group_label>Glass Ionomer with Glass Hybrid technology</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional high viscosity Glass Ionomer</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Comparator</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Conventional high viscosity glass ionomer</intervention_name>
    <description>Dental restorative material</description>
    <arm_group_label>Conventional high viscosity Glass Ionomer</arm_group_label>
    <other_name>GC EQUIA</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Glass ionomer with glass hybrid technology</intervention_name>
    <description>Dental restorative material</description>
    <arm_group_label>Glass Ionomer with Glass Hybrid technology</arm_group_label>
    <other_name>GC EQUIA Forte</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Bilateral class I carious lesions in their occlusal pits and fissures.

          -  High caries risk patients who has 1 or more cavitated lesion with risk factor declared
             by Caries Management By Risk Assessment (CAMBRA)

          -  Co-operative patients approving to participate in the trial.

        Exclusion Criteria:

          -  Disabilities.

          -  Systemic diseases or severe medically compromised.

          -  Lack of compliance.

          -  Evidence of severe bruxism, clenching or temporomandibular joint disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Mohamed R El-Bialy, Assistant lecturer</last_name>
    <phone>+201202552666</phone>
    <email>M.refaat.op@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Faculty of oral and dental medicine, cairo university</name>
      <address>
        <city>Cairo</city>
        <zip>11553</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Amira F El-Zoghby, Professor</last_name>
      <phone>+201222106620</phone>
      <email>Amfzh52@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Ahmed A El-Zohairy, Associate professor</last_name>
      <phone>+201227848002</phone>
      <email>Aelzohairy@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 1, 2016</study_first_submitted>
  <study_first_submitted_qc>August 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 5, 2016</study_first_posted>
  <last_update_submitted>August 2, 2016</last_update_submitted>
  <last_update_submitted_qc>August 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 5, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Mohamed Refaat El-Bialy</investigator_full_name>
    <investigator_title>Assistant lecturer</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methamphetamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

